the health outcomes or benefits associated with this procedure.
|
|
- Geoffrey Strickland
- 5 years ago
- Views:
Transcription
1 Original Issue Date (Created): October 4, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Cognitive rehabilitation may be considered medically necessary for treatment of the cognitive deficits acquired only as a result of neurologic impairment due to traumatic brain injury, stroke, or encephalopathy, and when performed as a distinct and definable component of a medically necessary comprehensive rehabilitation program (e.g., includes at least 3 hours per day of physical medicine treatment, speech therapy, and occupational therapy). Cognitive rehabilitation performed outside of a comprehensive rehabilitation program is considered investigational, as there is insufficient evidence to support a conclusion concerning the health outcomes or benefits associated with this procedure. Cognitive rehabilitation for the treatment of conditions, other than those described above, is considered investigational, as there is insufficient evidence to support a conclusion concerning the health outcomes or benefits associated with this procedure. Cross-references: MP Sensory Integration Therapy II. PRODUCT VARIATIONS [N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below [N] Capital Cares 4 Kids [N] PPO [N] HMO [Y] SeniorBlue HMO* [Y] SeniorBlue PPO* [N] Indemnity [N] SpecialCare [N] POS [Y] FEP PPO** * Refer to Novitas Solutions Inc. (LCD) L27513 Physical Medicine & Rehabilitation Services, PT and OT for other neurological disease coverage. **Refer to FEP Medical Policy Manual MP Cognitive Rehabilitation. The FEP Medical Policy manual can be found at: Page 1
2 III. DESCRIPTION/BACKGROUND Cognitive rehabilitation (CR) (also known as cognitive therapy, cognitive retraining, cognitive remediation, and cognitive behavior therapy) is a therapeutic approach designed to improve cognitive functioning after central nervous system insult. It includes an assembly of therapy methods that retrain or alleviate problems caused by deficits in attention, visual processing, language, memory, reasoning, problem solving, and executive functions. Cognitive rehabilitation consists of tasks designed to reinforce or re-establish previously learned patterns of behavior or to establish new compensatory mechanisms for impaired neurologic systems. Cognitive rehabilitation may be performed by a physician, psychologist, or a physical, occupational, or speech therapist. Cognitive rehabilitation must be distinguished from occupational therapy. Occupational therapy describes rehabilitation that is directed at specific environments (i.e., home or work). In contrast, cognitive rehabilitation consists of tasks designed to develop the memory, language, and reasoning skills that can then be applied to specific environments. IV. DEFINITIONS. COGNITIVE pertains to the mental processes of comprehension, judgment, memory, and reasoning, as contrasted with emotional and volitional process. CUTANEOUS pertains to the skin. ENCEPHALOPATHY refers to generalized (i.e., not localized) brain dysfunction marked by varying degrees of impairment of speech, cognition, orientation, and arousal. GUSTATORY pertains to the sense of taste. KINESTHETIC refers to the perception of one's own body parts, weight, and movement. PROTOCOL refers to a written plan specifying the procedures to be followed in giving a particular examination, in conducting research, or in providing care for a particular condition. Page 2
3 V. BENEFIT VARIATIONS The existence of this medical policy does not mean that this service is a covered benefit under the member s contract. Benefit determinations should be based in all cases on the applicable contract language. Medical policies do not constitute a description of benefits. A member s individual or group customer benefits govern which services are covered, which are excluded, and which are subject to benefit limits and which require preauthorization. Members and providers should consult the member s benefit information or contact Capital for benefit information. VI. DISCLAIMER Capital s medical policies are developed to assist in administering a member s benefits, do not constitute medical advice and are subject to change. Treating providers are solely responsible for medical advice and treatment of members. Members should discuss any medical policy related to their coverage or condition with their provider and consult their benefit information to determine if the service is covered. If there is a discrepancy between this medical policy and a member s benefit information, the benefit information will govern. Capital considers the information contained in this medical policy to be proprietary and it may only be disseminated as permitted by law. VII. REFERENCES Cognitive Rehabilitation 1997 TEC Assessments; Tab TEC Assessment February 2008) BCBSA TEC policy: "Cognitive Rehabilitation for Traumatic Brain Injury in Adults". December Bowen A, Lincoln NB. Cognitive rehabilitation for spatial neglect following stroke Cochrane Database Syst Rev 2007; (2):CD Cicerone KD, Mott T, Azulay J et al A randomized controlled trial of holistic neuropsychologic rehabilitation after traumatic brain injury Arch Phys Med Rehabil 2008; 89(12): Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for management of concussion/mild traumatic brain injury. Washington (DC): Department of Veteran Affairs, Department of Defense; 2009 Institute of Medicine, National Academies Press. Cognitive rehabilitation therapy for traumatic brain injury. 2011, October. [Website]: Rehabilitation-Therapy-for-Traumatic-Brain-Injury-Evaluating-the-Evidence.aspx Accessed December 31, Kurz A, Thone-Otto A, Cramer B et al. CORDIAL: Cognitive rehabilitation and cognitivebehavioral treatment for early dementia in Alzheimer disease. Alzheimer Dis Assoc Disord 2011 [Epub ahead of print]. Nair RD, Lincoln NB. Cognitive rehabilitation for memory deficits following stroke Cochrane Database Syst Rev 2007; (3):CD Page 3
4 Novitas Solutions Local Coverage Determination (LCD) L27513: Physical Medicine & Rehabilitation Services, PT and OT Effective06/13/13.. [Website]: 50_ca405e36e159/Page6.jspx?wc.contextURL=%2Fspaces%2FMedicareJL&_afrLoop= &wc.originURL=%2Fspaces%2FMedicareJL#%40%3F_afrLoop%3D %26wc.originURL%3D%252Fspaces%252FMedicareJL%26wc.contextURL %3D%252Fspaces%252FMedicareJL%26_adf.ctrl-state%3Du4dtga8z_204 Accessed December 31, Martin M, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011; (1):CD Sitzer DI, Twamley EJ, Jeste DW. Cognitive training in Alzheimer s disease: A meta-analysis of the literature. Acta Psychiatr Scand 2006; 114: Taber's Cyclopedic Medical Dictionary, 20 th edition VIII. CODING INFORMATION Note: This list of codes may not be all-inclusive, and codes are subject to change at any time. The identification of a code in this section does not denote coverage as coverage is determined by the terms of member benefit information. In addition, not all covered services are eligible for separate reimbursement. Covered when medically necessary: CPT Codes Current Procedural Terminology (CPT) copyrighted by American Medical Association. All Rights Reserved. ICD-9 Procedure codes Description Rehabilitation, not elsewhere classified ICD-9-CM Diagnosis Description Code* Cerebral thrombosis with cerebral infarction Cerebral embolism with cerebral infarction Unspecified cerebral artery occlusion with cerebral infarction Late effects of Cerebrovascular disease (Cognitive deficits ) Page 4
5 Hypoxic-Ischemic Encepholopathy, Unspecified Mild Hypoxic-Ischemic Encephalopathy Moderate Hypoxic-Ischemic Severe Hypoxic-Ischemic Encephalopathy Concussion with no loss of consciousness Intracranial injury of other and unspecified nature, without mention of open intracranial wound, unspecified state of consciousness Head injury unspecified V15.52 Personal History of Traumatic Brain Injury *If applicable, please see Medicare LCD or NCD for additional covered diagnoses. The following ICD-10 diagnosis codes will be effective October 1, 2015 ICD-10-CM Diagnosis Description Code* I63.30 Cerebral infarct due to thrombosis of unspecified cerebral artery I I Cerebral infarct due to thrombosis R and L middle cerebral artery I Cerebral infarct due to thrombosis unspecified middle cerebral artery I I Cerebral infarct due to thrombosis R and L anterior cerebral artery I I Cerebral infarct due to thrombosis R and L posterior cerebral artery I Cerebral infarct due to thrombosis unspecified posterior cerebral artery I Cerebral infarct due to thrombosis of R and L cerebellar artery I Cerebral infarct due to thrombosis of unspecified cerebellar artery I63.39 Cerebral infarct due to thrombosis of other cerebral artery I63.6 Cerebral infarct due to cerebral venous thrombosis, nonpyogenic I66.01 I66.03 Occlusion and stenosis of left, right and bilateral middle cerebral arteries I66.09 Occlusion of unspecified middle cerebral artery I66.11 I66.13 Occlusion and stenosis of left, right and bilateral anterior cerebral artery I66.19 Occlusion and stenosis of unspecified anterior cerebral artery I66.21 I66.23 Occlusion and stenosis of left, right and bilateral posterior cerebral artery I66.29 Occlusion and stenosis of unspecified posterior cerebral artery I66.3 Occlusion and stenosis of cerebellar arteries Page 5
6 I66.9 Occlusion and stenosis of unspecified cerebellar arteries I69.01 Cognitive deficits following nontraumatic subarachnoid hemorrhage I69.11 Cognitive deficits following nontraumatic intracerebral hemorrhage I69.21 Cognitive deficits following nontraumatic following other intracranial hemorrhage I69.31 Cognitive deficits following cerebral Infarct I69.81 Cognitive deficits following other cerebrovascular disease I69.91 Cognitive deficits following unspecified cerebrovascular disease P91.60 Hypoxic ischemic encephalopathy [HIE], unspecified P91.61 Mild hypoxic ischemic encephalopathy [HIE] P91.62 Moderate hypoxic ischemic encephalopathy [HIE] P91.63 Severe hypoxic ischemic encephalopathy [HIE] S06.0x0a Concussion without loss of consciousness, initial encounter S06.890A Other specified intracranial injury without loss of consciousness, initial encounter. S09.10XA Unspecified injury of muscle and tendon of head, initial encounter S09.11XA Strain of muscle and tendon of head, initial encounter S09.19XA Other specified injury of muscle and tendon of head, initial encounter S09.8XXA Other injuries of head, initial encounter S09.90XA Unspecified injury of head, initial encounter Z Personal history of traumatic brain injury *If applicable, please see Medicare LCD or NCD for additional covered diagnoses. IX. POLICY HISTORY MP CAC 2/25/03 CAC 9/28/04 CAC 9/27/05 CAC 11/29/05 CAC 10/31/06 CAC 11/27/07 CAC 11/25/08 CAC 9/29/09 Consensus Review CAC 9/28/10 Consensus Review CAC 10/25/11 Consensus Review. Added reference to MP Sensory Integration Therapy. Deleted information related to Sensory Stimulation - retired. CAC 8/28/12 Consensus Review. No change to policy statements. References updated. Page 6
7 Codes reviewed 8/29/12 klr CAC 7/30/13 Consensus Review. No change to policy statements. Admin code review completed. CAC 3/25/14 Consensus review. References updated. No change to the policy statements. ICD9 Surgical codes added. Health care benefit programs issued or administered by Capital BlueCross and/or its subsidiaries, Capital Advantage Insurance Company, Capital Advantage Assurance Company and Keystone Health Plan Central. Independent licensees of the BlueCross BlueShield Association. Communications issued by Capital BlueCross in its capacity as administrator of programs and provider relations for all companies. Page 7
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 26, 2011 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): 1/1/2012 Most Recent Review Date (Revised): 1/18/2018 Effective Date: 8/1/2018 RETIRED POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationMEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): 3/1/2012 Most Recent Review Date (Revised): 9/6/2018 Effective Date: 11/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER
More informationMEDICAL POLICY I. POLICY II. PRODUCT VARIATIONS POLICY TITLE AUDITORY BRAIN STEM IMPLANT POLICY NUMBER MP-1.085
Original Issue Date (Created): August 28, 2012 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Unilateral use of an auditory brainstem implant (using surface electrodes
More informationTo be considered medically necessary, an eligible provider must prescribe all orthotics.
Original Issue Date (Created): 2/1/2018 Most Recent Review Date (Revised): 9/26/2017 Effective Date: 4/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER
More informationMEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER CANAKINUMAB (ILARIS ) MP-2.147
Original Issue Date (Created): May 1, 2010 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Preauthorization is required for injectable Canakinumab (Ilaris ): Note:
More informationHead MRA/MRV studies of the head may be considered medically necessary for the following strongly suspected vascular diseases:
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: September 5, 2014 I. POLICY Head MRA/MRV studies of the head may be considered medically
More informationCognitive Rehabilitation
Last Review Date: March 10, 2017 Number: MG.MM.ME.58Cv2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: August 20, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPediatric Use: Safety and effectiveness of Ustekinumab (STELARA ) in pediatric patients have not been evaluated.
Original Issue Date (Created): January 1, 2010 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 I. POLICY Preauthorization Requirements for Ustekinumab (STELARA ) Note:
More information[N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below
Original Issue Date (Created): May 3, 2004 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY Mechanical insufflation-exsufflation (MI-E) may be considered
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 22, 2011 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 26, 2013 Most Recent Review Date (Revised): November 26, 2013 Effective Date: April 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationMEDICAL POLICY I. POLICY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Laser treatment of port wine stains in the presence of functional impairment
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): January 28, 2014 Most Recent Review Date (Revised): January 28, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationEmergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)
2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement
More informationMEDICAL POLICY No R4 NEUROPSYCHOLOGICAL AND PSYCHOLOGICAL TESTING
NEUROPSYCHOLOGICAL AND PSYCHOLOGICAL TESTING Effective Date: October 1, 2015 Review Dates: 7/07, 6/08, 6/09, 8/09, 8/10, 8/11, 8/12, 8/13, 8/14, 8/15, 8/16, 8/17 Date Of Origin: July 2007 Status: Current
More informationMEDICAL POLICY I. POLICY II. PRODUCT VARIATIONS POLICY TITLE POLICY NUMBER MANIPULATION UNDER ANESTHESIA MP-8.006
Original Issue Date (Created): October 04, 2003 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 I. POLICY Manipulation under anesthesia (MUA) may be considered medically
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationCognitive Rehabilitation
Medical Coverage Policy Cognitive Rehabilitation Table of Contents Coverage Policy... 1 Overview... 2 General Background... 2 Coding/Billing Information... 11 References... 18 Effective Date... 5/15/2017
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): April 24, 2012 Most Recent Review Date (Revised): May 20, 2014 Effective Date: August 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: July 24, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationProtocol. cogn. Cognitive Rehabilitation
cogn Protocol Cognitive Rehabilitation (80310) Medical Benefit Effective Date: 07/01/16 Next Review Date: 05/18 Preauthorization Yes Review Dates: 04/07, 05/08, 05/09, 05/10, 09/10, 09/11, 07/12, 05/13,
More informationNeuropsychological Testing
Last Review Date: June 27, 2017 Number: MG.MM.ME.18fv2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: July 15, 2018 Related Policies: None Cognitive Rehabilitation Description Cognitive rehabilitation is a therapeutic approach designed to improve cognitive functioning
More informationMEDICAL POLICY I. POLICY II. PRODUCT VARIATIONS TOP III. DESCRIPTION/BACKGROUND POLICY TITLE SPHENOPALATINE GANGLION BLOCK POLICY NUMBER MP-4.
Original Issue Date (Created): 2/1/2018 Most Recent Review Date (Revised): 7/5/2018 Effective Date: 9/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER
More informationMEDICAL POLICY I. POLICY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): September 25, 2012 Effective Date: October 1, 2012 I. POLICY Cervicography Cervicography is considered investigational, as
More informationMEDICAL POLICY No R9 DETOXIFICATION I. POLICY/CRITERIA
DETOXIFICATION MEDICAL POLICY Effective Date: January 1, 2018 Review Dates: 1/93, 2/97, 4/99, 2/01, 12/01, 2/02, 2/03, 1/04, 1/05, 12/05, 12/06, 12/07, 12/08, 12/09, 12/10, 12/11, 12/12, 12/13, 11/14,
More informationJAWDA Guidelines for Pre-hospital Emergency Medical Service (EMS)
JAWDA Guidelines for Pre-hospital Emergency Medical Service (EMS) January 2019 Page 1 of 17 Table of Contents Executive Summary... 3 About this Guidance... 4 Emergency Medical Service Performance Indicators...
More informationINDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding updates, inclusion of a code on the code tables
More informationSAMPLE. Laboratory Services. An essential coding, billing, and reimbursement resource for laboratory and pathology services ICD-10
Coding and Payment Guide www.optumcoding.com Laboratory Services An essential coding, billing, and reimbursement resource for laboratory and pathology services 2017 ICD-10 A full suite of resources including
More informationMedicare Part C Medical Coverage Policy
Medicare Part C Medical Coverage Policy Neuropsychological Testing Origination: September 19, 2001 Review Date: February 21, 2018 Next Review: February, 2020 DESCRIPTION OF PROCEDURE SERVICE Neuropsychological
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 26, 2013 Most Recent Review Date (Revised): November 26, 2013 Effective Date: April 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationICD-9 to ICD-10 Crosswalk Adult Codes
ICD- to ICD- Crosswalk Adult Codes On October 1, 2015, the Centers for Medicare & Medicaid Services (CMS) transitioned to the new International Classification of Diseases, th Revision System (ICD-), which
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): December 8, 2003 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationCerebrovascular accident icd 10
Cerebrovascular accident icd 10 I69.21 is a billable ICD code used to specify a diagnosis of cognitive deficits following other nontraumatic intracranial hemorrhage. A 'billable code' is detailed. Conventions.
More informationMEDICAL POLICY I. POLICY POLICY TITLE PARENTERAL HOME INFUSION THERAPY (INCLUDING TOTAL PARENTERAL NUTRITION) MP-3.
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY Home infusion services may be considered medically necessary
More informationMEDICAL POLICY PEGLOTICASE (KRYSTEXXA ) POLICY NUMBER MP POLICY TITLE. Original Issue Date (Created): January 1, 2011
Original Issue Date (Created): January 1, 2011 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY PREAUTHORIZATION REQUIRED Note: Requests for pegloticase
More informationLnformation Coverage Guidance
Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It
More informationCOGNITIVE REHABILITATION
COGNITIVE REHABILITATION MEDICAL POLICY Policy Number: 2014T0144M Effective Date: May 1, 2014 Table of Contents BENEFIT CONSIDERATIONS COVERAGE RATIONALE APPLICABLE CODES.. DESCRIPTION OF SERVICES... CLINICAL
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 30, 2013 Most Recent Review Date (Revised): May 20, 2014 Effective Date: August 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationClinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155
Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy
More informationSUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS
MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationSympathetic Electrical Stimulation Therapy for Chronic Pain
Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE
More informationHAAD quality KPI; waiting time
Type: Waiting Time Indicator Indicator Number: WT001 Primary Care Appointment- Outpatient Setting Time to see a HAAD licensed family physician or member of their team (GP) Time of request (walk-in or by
More informationThe determination of eligible population for this measure requires administrative claims data.
Overuse of Imaging Measure 6: Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Headache Description This measure assesses the ratio
More informationJAWDA Quarterly Waiting Time Guidelines for (Specialized and General Hospitals)
JAWDA Waiting Time Guidelines for (Specialized and General Hospitals) January 2019 Page 1 of 22 Table of Contents Executive Summary... 3 About this Guidance... 4 Performance Indicators... 5 APPENDIX -
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 26, 2013 Most Recent Review Date (Revised): November 26, 2013 Effective Date: April 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationPhysical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy
Policy Number Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy 2017R0101E Annual Approval Date 7/13/2016 Approved By Payment Policy Oversight Committee IMPORTANT NOTE ABOUT
More informationPhysical Therapy Diagnosis and Documentation Tips
1 This tool is designed to assist the Physical Therapist in consultation with the physician, in the selection of an appropriate according to Medicare coverage guidelines. The documentation tips will add
More informationMEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER INHALED NITRIC OXIDE MP-4.021
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 I. POLICY Inhaled nitric oxide may be considered medically necessary as
More informationPhysical Therapy MM /15/2003
Physical Therapy Policy Number: Original Effective Date: MM.09.005 07/15/2003 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 06/23/2017 Line(s) of Business Excluded: Federal Employee
More informationMEDICAL POLICY I. POLICY. POLICY TITLE POLICY NUMBER OMALIZUMAB (XOLAIR ) MP-2.123
Original Issue Date (Created): May 3, 2004 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY. Note: Initial Authorization If the patient has been maintained
More informationCorporate Medical Policy
Corporate Medical Policy Cognitive Rehabilitation Description of Procedure or Service Cognitive Rehabilitation Therapy (CRT) is therapeutic treatment provided to retrain the injured brain in its cognitive
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): August 02, 2002 Most Recent Review Date (Revised): May 20, 2014 Effective Date: August 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Magnetic Resonance Angiography (L34424) Document Information
Local Coverage Determination (LCD): Magnetic Resonance Angiography (L34424) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
More informationEmpire BlueCross BlueShield Professional Commercial Reimbursement Policy
Subject: Documentation Guidelines for Central Nervous System Assessments and Tests NY Policy: 0046 Effective: 12/01/2014 11/30/2015 Coverage is subject to the terms, conditions, and limitations of an individual
More informationMobile Cardiac Outpatient Telemetry (Real-Time, Outpatient Cardiac Monitoring )
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): May 14, 2013 Effective Date: September 1, 2013 I. POLICY Ambulatory Event Monitors External The use of patient-activated or
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): June 18, 2007 Most Recent Review Date (Revised): March 25, 2014 Effective Date: July 17, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): April 24, 2012 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationCerebrovascular accident icd 10
Cerebrovascular accident icd 10 Search 1-10-2017 Free, official coding info for 2018 ICD - 10 -CM I69.398 - includes detailed rules, notes, synonyms, ICD -9-CM conversion, index and annotation crosswalks,
More informationSubject: Cognitive Rehabilitation for Traumatic Brain Injury
Subject: Cognitive Rehabilitation for Traumatic Brain Injury Guidance Number: MCG-144 Revision Date(s): Original Effective Date: 8/28/2013 Medical Coverage Guidance Approval Date: 8/28/2013 PREFACE This
More informationMEDICAL POLICY I. POLICY POLICY TITLE VISUAL FIELD TESTING POLICY NUMBER MP
Original Issue Date (Created): August 9, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Sensorimotor and Neurobehavioral Status Exams Page 1 of 5 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Sensorimotor and Neurobehavioral Status Exams for Optometric
More informationCognitive Rehabilitation Therapy
Cognitive Rehabilitation Therapy Policy Number: Original Effective Date: MM.09.001 08/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/30/2016 Section: Rehabilitative
More informationMedical Policy. Title: Cognitive Rehabilitation
Medical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information only. These documents are not to be used to determine benefits or reimbursement. Please reference the appropriate
More informationProduct Name or Headline
Product Name or Headline Subhead goes here Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding, or site of service requirements. The coding options listed
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: April 01, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationClinical Policy: Homocysteine Testing Reference Number: CP.MP.121
Clinical Policy: Reference Number: CP.MP.121 Effective Date: 08/16 Last Review Date: 08/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Document Information
Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor
More informationNon-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.
COGNITIVE THERAPY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationAppendix e-1. University HealthSystem Consortium (UHC) database description
Appendix e-1. University HealthSystem Consortium (UHC) database description UHC is an alliance of academic medical centers and their affiliated hospitals. Member institutions have the goal of sharing clinical,
More informationDocumentation for the IRF Provider
Documentation for the IRF Provider Timothy N. Brundage, MD, CCDS Certified Clinical Documentation Specialist DrBrundage@gmail.com 1 Medicare controls the ball field If you want to play ball, you have to
More informationNicolas Bianchi M.D. May 15th, 2012
Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the
More informationIntrathecal Baclofen for CNS Spasticity
Intrathecal Baclofen for CNS Spasticity Last Review Date: October 13, 2017 Number: MG.MM.ME.31bC7 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary
More informationcustom fused glass tile Important Copy: custom glass tile and fused glass tile Custom Glass Tile
custom fused glass tile Custom Glass Tile Important Copy: custom glass tile and fused glass tile I63.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
More informationCMS Limitations Guide MRA Radiology Services
CMS Limitations Guide MRA Radiology Services Starting July 1, 2008, CMS has placed numerous medical necessity limits on tests and procedures. This reference guide provides you with all of the latest changes.
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): June 4, 2013 Most Recent Review Date (Revised): March 25, 2014 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More information[N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below
Original Issue Date (Created): July 26, 2011 Most Recent Review Date (Revised): November 26, 2013 Effective Date: February 1, 2014 I. POLICY The use of percutaneous left-atrial appendage closure devices
More informationOccipital lobe infarct icd 9
P ford residence southampton, ny Occipital lobe infarct icd 9 Lobes of the human brain (the occipital lobe is shown in red) Medial surface of left cerebral hemisphere. (cuneus and lingual gyrus are at
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): 3/8/2004 Most Recent Review Date (Revised): 1/12/2018 Effective Date: 10/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): November 26, 2013 Effective Date: June 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationClinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156
Clinical Policy: Reference Number: CP.MP.156 Effective Date: 12/17 Last Review Date: 12/17 See Important Reminder at the end of this policy for important regulatory and legal information. Description The
More informationKANSAS MEDICAL ASSISTANCE PROGRAM. Fee-for-Service Provider Manual. Rehabilitative Therapy Services
Fee-for-Service Provider Manual Rehabilitative Therapy Services Updated 12.2015 PART II (PHYSICAL THERAPY, OCCUPATIONAL THERAPY, SPEECH/LANGUAGE PATHOLOGY) Introduction Section BILLING INSTRUCTIONS Page
More informationClinical Policy: Cochlear Implant Replacements
Clinical Policy: Reference Number: CP.MP.14 Last Review Date: 07/18 Revision Log Coding Implications See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationPremier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:
Premier Health Plan POLICY AND PROCEDURE MANUAL MP.091.PH - Intravascular Ultrasound for Coronary Vessels This policy applies to the following lines of business: Premier Commercial Premier Employee Premier
More informationNo An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.
No. 158. An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.223) It is hereby enacted by the General Assembly of the State
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.049.MH Visually Evoked Response Test This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): February 28, 2012 Most Recent Review Date (Revised): May 20, 2014 Effective Date: August 13, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationPremier Health Plan considers Iontophoresis for Musculoskeletal Conditions medically necessary for the following indications:
Premier Health Plan POLICY AND PROCEDURE MANUAL MP.036.PH - Iontophoresis for Musculoskeletal Conditions This policy applies to the following lines of business: Premier Commercial Premier Employee Premier
More informationMEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS
MEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationSupplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
More informationClinical Policy: Cochlear Implant Replacements Reference Number: CP.MP.14
Clinical Policy: Reference Number: CP.MP.14 Effective Date: 02/09 Last Review Date: 09/17 Revision Log Coding Implications See Important Reminder at the end of this policy for important regulatory and
More information2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)
2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse
More informationClinical Policy Title: Neuro- and brain injury life skills and rehabilitation
Clinical Policy Title: Neuro- and brain injury life skills and rehabilitation Clinical Policy Number: 09.02.06 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review
More information